Neuroinflammatory-IN-2
Modify Date: 2024-01-16 14:30:50
Neuroinflammatory-IN-2 structure
|
Common Name | Neuroinflammatory-IN-2 | ||
|---|---|---|---|---|
| CAS Number | 2361384-14-5 | Molecular Weight | 422.49 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H27FN2O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Neuroinflammatory-IN-2Neuroinflammatory-IN-2 (compound 7i) is a potent anti-neuroinflammatory agent with an IC50 value of 10.30 μM for MAO-B, and 96.33% inhibition of Aβ1-42 aggregation at 25 μM. Neuroinflammatory-IN-2 has neuroprotective activity in H2O2-induced PC-12 cell injury. Neuroinflammatory-IN-2 also has biometal chelating abilities, antioxidant activity, anti-neuroinflammatory activity and appropriate BBB permeability. Neuroinflammatory-IN-2 can be used for researching Alzheimer’s disease[1]. |
| Name | Neuroinflammatory-IN-2 |
|---|
| Description | Neuroinflammatory-IN-2 (compound 7i) is a potent anti-neuroinflammatory agent with an IC50 value of 10.30 μM for MAO-B, and 96.33% inhibition of Aβ1-42 aggregation at 25 μM. Neuroinflammatory-IN-2 has neuroprotective activity in H2O2-induced PC-12 cell injury. Neuroinflammatory-IN-2 also has biometal chelating abilities, antioxidant activity, anti-neuroinflammatory activity and appropriate BBB permeability. Neuroinflammatory-IN-2 can be used for researching Alzheimer’s disease[1]. |
|---|---|
| Related Catalog | |
| Target |
MAO-B:10.30 μM (IC50) |
| In Vitro | Neuroinflammatory-IN-2 (compound 7i) (1 and 10 μM) dramatically increases the viability of H2O2-treated PC-12 cells by 70.2% and 81.6% at 1 and 10 μM, respectively[1]. Neuroinflammatory-IN-2 (0.5, 2.5 and 10.0 μM) inhibits NO expression in LPS-stimulated BV-2 cells by 32.4%, 46.7% and 57.2% at the concentration of 0.5, 2.5 and 10.0 μM respectively; and inhibits TNF-α by 35.8%, 53.1% and 76.5%, respectively[1]. |
| References |
| Molecular Formula | C25H27FN2O3 |
|---|---|
| Molecular Weight | 422.49 |